Cardiovascular

InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial

2 min

FDA Approval of Elarekibart: Current Status and Market Implications

FDA · treatment-resistant hypertension · 8 min

FDA Approval of Sotatercept: Market Impact and Clinical Outlook for Winrevair

FDA · pulmonary arterial hypertension · 8 min

Lilly's Foundayo Shows 57% Mortality Reduction in Landmark ACHIEVE-4 Diabetes Trial

Type 2 Diabetes with Cardiovascular Benefits · 3 min

Medera's AAV-SERCA2a Gene Therapy Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Cardiomyopathy

FDA · 2 min

Vasa Therapeutics Partners with Eli Lilly's TuneLab AI Platform for CAMKII Inhibitor Development

2 min

FDA Priority Review Granted to PharmaGiant's CholesterolRx for High Cholesterol

FDA · Cardiovascular · 6 min

FDA Approves Repatha: Key Details on Amgen's Cardiovascular Drug

FDA · Cardiovascular Disease · 4 min